Drug firm Zydus Cadila today said it has received approval from the US health regulator to market anti-histamine Cyproheptadine Hydrochloride tablets in the US market. The company has received final approval from the United States Food and Drug Administration (USFDA) to market Cyproheptadine Hydrochloride tablets in the strength of 4 mg, Cadila Healthcare said in […]

HMD Healthcare Ltd, known as Hindustan Syringes & Medical Devices LTD, one of the largest manufacturer of disposable syringes in the world and the largest for auto disable syringes, is all set to enter South American market.

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of Insulin lispro Sanofi (insulin lispro 100 Units/mL).

Dabur India said it is acquiring two South African companies in the personal care and hair care segment. In a BSE filing, the company said its, “step down wholly-owned subsidiary Dabur South Africa has entered into a share purchase agreement to acquire D&A Cosmetics Proprietary Ltd and Atlanta Body & Health Products Proprietary Ltd.”

Dr Reddy’s Laboratories Ltd. has received approval from the US Food and Drug Administration (FDA) to launch doxorubicin hydrochloride liposome injection, a therapeutic equivalent generic version of Doxil (doxorubicin hydrochloride liposome injection), for intravenous use, in the United States market. The US FDA approval is an outcome of extensive collaboration with the company’s partner, Natco […]

Alcon, the global leader in eye care and a division of Novartis, has introduces the CyPass Micro-Stent, a micro invasive glaucoma surgical (MIGS) device, in EU markets for the treatment of patients with mild to moderate primary open-angle glaucoma in conjunction with cataract surgery, or as a standalone procedure in patients with primary open-angle glaucoma […]

The United States Food and Drug Administration (FDA) has approved Inspirion Delivery Sciences’ RoxyBond (oxycodone hydrochloride) tablets, for oral use, CII, indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Almost five years after the launch of the revolutionary bio-resorbable stents in India, Union health authorities on Monday issued a medical alert cautioning patients and doctors and asking them to report any problems. The Central Drugs Standard Control Organization (CDSCO)’s note posted on its website cited “safety concerns” as the reason. “Based on three years’ […]